益豐藥房(603939.SH):控股股東股權結構變動
格隆匯 1 月 22日丨益豐藥房(603939.SH)公佈,近日,公司收到控股股東濟康管理的通知,因2020年9月減持公司股份(具體內容詳見2020年9月22日公司公吿:2020-090號),該次減持為控股股東內部合夥人之間不同比例的減持,根據《合夥企業法》,濟康管理對各合夥人的出資額進行不同比例的減資,導致濟康管理總出資額以及各合夥人出資比例發生變化,並於近日完成工商變更登記。
此次濟康管理合夥人出資比例發生變化後,高毅直接和間接持有濟康管理的出資比例為59.86%(長沙益之康諮詢有限公司持有濟康管理0.32%出資,其為高毅一人獨資公司),濟康管理目前持有公司129,078,000股無限售流通股,佔公司總股本的24.28%,此次濟康管理合夥人出資比例變動未導致其持有公司股票數量和比例發生變化,仍為公司控股股東。
截止2020年12月31日,高毅通過濟康管理、益之豐、益仁堂以及其本人直接持股,分別控制公司24.28%、1.37%、0.63%和12.19%股份,合計控制公司38.47%的股份。高毅仍為公司實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.